文献速递骨肿瘤

在军队环境中执业的接受专科进修教育的军队骨科肿瘤学家是否治疗足够数量的患者以维持其肿瘤学专业技能?

Do Fellowship-educated Military Orthopaedic Oncologists Who Practice in Military Settings Treat a Sufficient Volume of Patients to Maintain Their Oncologic Expertise?
PubMed 文献 · Clin Orthop Relat Res · 2024-10-30

本研究利用军队数据仓库回顾性分析2013至2022财年9名军队骨科肿瘤学家的诊疗模式,发现796例次诊断中仅13%为肿瘤相关,其中45%为恶性,平均每名外科医生每年治疗2例原发和2.5例继发恶性肿瘤患者,共完成5996例手术(每人每年74例),其中21%为肿瘤手术。结论认为军队骨科肿瘤学家虽具备可转化为战伤救治的技能,但在军队医疗系统内接诊的肿瘤患者相对较少,且不足一半为恶性肿瘤。

要点

  • 军队骨科肿瘤学家年均治疗原发恶性肿瘤2例、继发恶性肿瘤2.5例。
  • 9名骨科肿瘤学家共完成5996例手术,人均每年74例,其中21%为肿瘤手术。
  • 肿瘤相关诊断仅占13%(796/5996),其中45%为恶性。

核心结论

  • 军队骨科肿瘤学家具备可直接转化用于战伤救治和作战准备的专家技能,但在军队医疗系统医院内治疗的肿瘤诊断患者相对较少,且不足一半涉及恶性肿瘤。

研究设计与样本

  • 回顾性查询军队数据仓库,纳入2013至2022财年9名现役军队骨科肿瘤学家基于国家提供者标识符的所有手术,按常见诊断和手术类别分层统计。

主要发现

  • 5996例次诊断中13%(796/5996)为肿瘤相关,其中45%(357/796)为恶性;恶性中44%(158/357)为原发、56%(199/357)为继发,折合每名外科医生每年治疗2例原发和2.5例继发恶性肿瘤患者。
  • 研究期间9名骨科肿瘤学家共完成5996例骨科手术,折合每名外科医生每年74例;其中21%(1252/5996)为肿瘤手术,其余包括897例关节置换、502例骨折相关、275例非肿瘤指征截肢、204例感染、142例关节镜和2724例其他手术。

临床怎么用

  • 作者认为,与高容量癌症中心的军民合作可能使军队骨科肿瘤学家在民用癌症中心工作以增加其肿瘤手术量,从而确保维持作战相关的知识、技能和能力并改善患者照护与结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fellowship-trained orthopaedic oncologists in the US military provide routine clinical care and also must maintain readiness to provide combat casualty care. However, low oncologic procedure volume may hinder the ability of these surgeons to maintain relevant surgical expertise. Other low-volume specialties within the Military Health System (MHS) have established partnerships with neighboring civilian centers to increase procedure volume, but the need for similar partnerships for orthopaedic oncologists has not been examined. The purpose of this study was to characterize the practice patterns of US military fellowship-trained orthopaedic oncologists. QUESTIONS/PURPOSES: We asked the following questions: (1) What are the diagnoses treated by US military fellowship-trained orthopaedic oncologists? (2) What are the procedures performed by US military fellowship-trained orthopaedic oncologists? METHODS: We queried the Military Data Repository, a centralized repository for healthcare data for all healthcare beneficiaries (active duty, dependents, and retirees) within the Defense Health Agency using the MHS's Management and Reporting Tool for all international common procedure taxonomy (CPT) codes and ICD-9 and ICD-10 codes associated with National Provider Identifier (NPI) numbers of active duty, military fellowship-trained orthopaedic oncologists. Fellowship-trained orthopaedic oncologists were identified by military specialty leaders. Then, we identified all procedures performed by the orthopaedic oncologist based on NPI numbers for fiscal years 2013 to 2022. We stratified the CPT codes by top orthopaedic procedure categories (such as amputation [performed for oncologic and nononcologic reasons], fracture, arthroplasty, oncologic) based on associated ICD codes. These were then tabulated by the most common diagnoses treated. RESULTS: Thirteen percent (796 of 5996) of the diagnoses were oncologic, of which 45% (357 of 796) were malignant. Forty-four percent (158 of 357) of the malignancies were primary and 56% (199 of 357) were secondary; this translates to an average of 2 patients with primary and 2.5 patients with secondary malignancies treated per surgeon per year. During the study period, nine orthopaedic oncologists performed 5996 orthopaedic procedures, or 74 procedures per surgeon per year. Twenty-one percent (1252 of 5996) of the procedures were oncologic; the remaining procedures included 897 arthroplasties, 502 fracture-related, 275 amputations for a nononcologic indication, 204 infections, 142 arthroscopic, and 2724 other procedures. CONCLUSION: Although military orthopaedic oncologists possess expert skills that are directly translatable to combat casualty care and operational readiness, within MHS hospitals they treat relatively few patients with oncologic diagnoses, and less than one-half of those involve malignancies. CLINICAL RELEVANCE: Despite postgraduation procedure volume raining stable over the last decade, it is unknown how many new patient visits for oncologic diagnoses and how many corresponding tumor procedures are necessary to maintain competence or build confidence after musculoskeletal oncology fellowship training. It is important to note that there are no military orthopaedic oncology fellowships, and all active duty orthopaedic oncologists undergo training at civilian institutions. Military-civilian partnerships with high-volume cancer centers may enable military orthopaedic oncologists to work at civilian cancer centers to increase their oncologic volume to ensure sustainment of operationally relevant knowledge, skills, and abilities and improve patient care and outcomes.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Anderson AB, Rivera JA, Flint JH, et al. Do Fellowship-educated Military Orthopaedic Oncologists Who Practice in Military Settings Treat a Sufficient Volume of Patients to Maintain Their Oncologic Expertise? Clin Orthop Relat Res. 2024. PMID: 39485936. doi:10.1097/CORR.0000000000003290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。